These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 34607697)
21. Minocycline for acne vulgaris: efficacy and safety. Garner SE; Eady EA; Popescu C; Newton J; Li WA Cochrane Database Syst Rev; 2003; (1):CD002086. PubMed ID: 12535427 [TBL] [Abstract][Full Text] [Related]
22. Minocycline for acne vulgaris: efficacy and safety. Garner SE; Eady EA; Popescu C; Newton J; Li Wan Po A Cochrane Database Syst Rev; 2000; (2):CD002086. PubMed ID: 10796856 [TBL] [Abstract][Full Text] [Related]
23. Dapsone for acne: Still in use after half a century! Searle T; Al-Niaimi F; Ali FR J Cosmet Dermatol; 2021 Jul; 20(7):2036-2039. PubMed ID: 33600049 [TBL] [Abstract][Full Text] [Related]
24. Cortexolone 17α-propionate 1% cream, a new potent antiandrogen for topical treatment of acne vulgaris. A pilot randomized, double-blind comparative study vs. placebo and tretinoin 0·05% cream. Trifu V; Tiplica GS; Naumescu E; Zalupca L; Moro L; Celasco G Br J Dermatol; 2011 Jul; 165(1):177-83. PubMed ID: 21428978 [TBL] [Abstract][Full Text] [Related]
25. Topical Retinoids in Acne Vulgaris: A Systematic Review. Kolli SS; Pecone D; Pona A; Cline A; Feldman SR Am J Clin Dermatol; 2019 Jun; 20(3):345-365. PubMed ID: 30674002 [TBL] [Abstract][Full Text] [Related]
26. Clinical Pharmacokinetics, Safety and Exploratory Efficacy Study of a Topical Bactericidal VB-1953: Analysis of Single and Multiple Doses in a Phase I Trial in Acne Vulgaris Subjects. Jain S; Yadav V; Bhatia N Clin Drug Investig; 2020 Mar; 40(3):259-268. PubMed ID: 31927743 [TBL] [Abstract][Full Text] [Related]
27. Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris. Marks DH; Prasad S; De Souza B; Burns LJ; Senna MM Am J Clin Dermatol; 2020 Apr; 21(2):245-254. PubMed ID: 31832993 [TBL] [Abstract][Full Text] [Related]
28. Potential Role for Topical Antiandrogens in the Management of Acne Among Patients Receiving Masculinizing Hormone Therapy. Marks DH; Mansh MD JAMA Dermatol; 2020 Dec; 156(12):1380-1381. PubMed ID: 33146681 [No Abstract] [Full Text] [Related]
29. Drugs for acne. Med Lett Drugs Ther; 2020 Nov; 62(1612):188-191. PubMed ID: 33443492 [No Abstract] [Full Text] [Related]
30. Dapsone 5% gel: a review of its efficacy and safety in the treatment of acne vulgaris. Stotland M; Shalita AR; Kissling RF Am J Clin Dermatol; 2009; 10(4):221-7. PubMed ID: 19489655 [TBL] [Abstract][Full Text] [Related]
31. Potential Role for Topical Antiandrogens in the Management of Acne Among Patients Receiving Masculinizing Hormone Therapy-Reply. Thiboutot D; Cartwright M; Mazzetti A JAMA Dermatol; 2020 Dec; 156(12):1381. PubMed ID: 33146696 [No Abstract] [Full Text] [Related]
34. A New Class of Topical Acne Treatment Addressing the Hormonal Pathogenesis of Acne. Barbieri JS JAMA Dermatol; 2020 Jun; 156(6):619-620. PubMed ID: 32320045 [No Abstract] [Full Text] [Related]
35. An evaluation of dapsone gel 5% in the treatment of acne vulgaris. Pickert A; Raimer S Expert Opin Pharmacother; 2009 Jun; 10(9):1515-21. PubMed ID: 19505219 [TBL] [Abstract][Full Text] [Related]
36. The use of hormonal agents in the treatment of acne. Hassoun LA; Chahal DS; Sivamani RK; Larsen LN Semin Cutan Med Surg; 2016 Jun; 35(2):68-73. PubMed ID: 27416311 [TBL] [Abstract][Full Text] [Related]
37. New Acne Therapies and Updates on Use of Spironolactone and Isotretinoin: A Narrative Review. Han JJ; Faletsky A; Barbieri JS; Mostaghimi A Dermatol Ther (Heidelb); 2021 Feb; 11(1):79-91. PubMed ID: 33409936 [TBL] [Abstract][Full Text] [Related]
38. Minocycline for acne vulgaris: efficacy and safety. Garner SE; Eady A; Bennett C; Newton JN; Thomas K; Popescu CM Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD002086. PubMed ID: 22895927 [TBL] [Abstract][Full Text] [Related]